General medical journalCurrentRheuma coverage

New England Journal of Medicine

What CurrentRheuma has captured from this journal. The coverage figures describe CurrentRheuma's coverage, not the journal's output. Figures as of 14 November 2026.

CurrentRheuma holds 21 Briefs from New England Journal of Medicine, most often randomized controlled trials and other research.

Recent
2 Briefs
past 90 days
Archive
21 Briefs
research published Oct 2025 – today, Oct 2024 – Jun 2025, Oct 2023 – Jun 2024 and Apr–Jun 2023
Editorial
–
no Weekly issue published yet

Topics

Evidence types

Shares are of the 21 Briefs CurrentRheuma has covered from N Engl J Med, by primary topic and study type.

Publication activity

Latest from New England Journal of Medicine

All coverage, newest first
  1. N Engl J Med

  2. N Engl J Med

  3. N Engl J Med

    Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica

    Randomized controlled trialVasculitis & PMR

  4. N Engl J Med

    Obexelimab for the Treatment of IgG4-Related Disease

    Randomized controlled trialAutoinflammatory & rare

  5. N Engl J Med

  6. N Engl J Med

    A Phase 3 Trial of Brepocitinib in Dermatomyositis

    Randomized controlled trialMyositis

  7. N Engl J Med

  8. N Engl J Med

  9. N Engl J Med

  10. N Engl J Med

    A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

    Randomized controlled trialVasculitis & PMR

  11. N Engl J Med

  12. N Engl J Med

  13. N Engl J Med

    Inebilizumab for Treatment of IgG4-Related Disease

    Randomized controlled trialAutoinflammatory & rare

  14. N Engl J Med

  15. N Engl J Med

  16. N Engl J Med

  17. N Engl J Med

  18. N Engl J Med

  19. N Engl J Med

  20. N Engl J Med

  21. N Engl J Med